Evolus Stock (NASDAQ: EOLS) stock price, news, charts, stock research, profile.
Open | $15.43 |
Close | $15.86 |
Volume / Avg. | 757.61K / 498.49K |
Day Range | $15.31 - $16.29 |
52 Wk Range | 7.44 - 15.91 |
Market Cap | $1.00B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 77 |
Short Interest | 8.15% |
Days to Cover | 14.67 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Evolus (NASDAQ:EOLS) through any online brokerage.
Other companies in Evolus’s space includes: GH Research (NASDAQ:GHRS), WAVE Life Sciences (NASDAQ:WVE), Tarsus Pharmaceuticals (NASDAQ:TARS), Rapport Therapeutics (NASDAQ:RAPP) and Phibro Animal Health (NASDAQ:PAHC).
Evolus has a consensus price target of $20.50.
The stock price for Evolus (NASDAQ: EOLS) is $15.86 last updated August 23, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Evolus.
Evolus’s Q3 earnings are confirmed for Tuesday, November 5, 2024.
There is no upcoming split for Evolus.
Evolus is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.